Understand relationships between disease, expertise, capability, research and organisations.
WHAT WE PROVIDE
Seven audiences. Seven defined products.
Disease Intelligence is not one vague dashboard for everyone. Each audience receives a different workspace, different workflows and a different commercial plan.
Patients & public
DI Navigate
Find credible routes without paying for clinical ranking.
Starts at€0
See exactly what you get →Physicians & practicesDI Clinician
Route cases, inspect evidence, discover trials and manage referrals.
Starts at€49/mo Pro
See exactly what you get →Hospitals & health systemsDI Health System
Manage capabilities, referrals, demand, network partners and evidence quality.
Starts at€1,500/mo
See exactly what you get →Pharma & CROsDI Life Sciences
Investigate trials, sites, investigators, capabilities and geographic opportunity.
Starts at€4,900/mo
See exactly what you get →Researchers & universitiesDI Research
Map researchers, trials, evidence and collaboration opportunities.
Starts at€29/mo Pro
See exactly what you get →Government & public healthDI Public Sector
Analyse coverage, access gaps, capability and regional system signals.
Starts at€30k pilot
See exactly what you get →Technology & partnersDI API / White Label
Embed Disease Intelligence into other products and institutional systems.
Starts at€99/mo API
See exactly what you get →WHAT IS SHARED?
One intelligence foundation powers every product.
The products differ by user, but they share the same core model: disease entities, capabilities, organisations, evidence, research, access, referrals, permissions and change signals.
See provenance, freshness, verification and uncertainty instead of unexplained scores.
Turn intelligence into a route, referral, verification task, site investigation or report.
Monitor saved concepts and workspaces for meaningful changes over time.
WHAT WE DO NOT SELL
Clinical ranking is not an advertising product.
Hospitals and clinicians can pay for software, workflows, analytics, verification and integrations. Payment does not buy a more clinically relevant ranking.